In the non-cancerous cellular domain, NFE2L2 gene variants affect metabolic and renal function parameters in patients with diabetes and hypertension [42]; are also genetic markers of susceptibility to cirrhosis [43] ; and evidence has even been found in the effect of obesity on heart rate [44]. Here, NFE2L2 is linked to Cirrhosis.